
|Articles|September 15, 2004
Note differences between optic nerve diseases
Los Angeles-Chronic progressive optic neuritis or optic nerve sheath meningioma? Until fairly recently, differentiating these two clinical entities would not have affected the clinical outcome because of the lack of an established safe, efficacious treatment for either condition. However, things have changed, said Howard R. Krauss, MD.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
4DMT releases positive interim 1.5- to 3.5-year data from phase 1/2 PRISM trial
2
Q&A: Karolinne M. Rocha discusses the IOL and patient tolerance of residual astigmatism
3
Beyond The Walls: The “how and why” behind what drives today’s ophthalmologists
4
Optigo Biotherapeutics names Andreas Wallnöfer, PhD, MBA, to board as lead retinal program advances
5


















































.png)


